Clinical Trials
3 trialsNCT00285350 2015-03-25
Mycophenolate Mofetil in Myasthenia Gravis
FDA Office of Orphan Products Development
Phase 3 Completed
NCT00997412 2009-10-19
Myfortic
Qualitix Clinical Research Co., Ltd.
Phase NA Unknown
NCT00683969 2008-05-26
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Hoffmann-La Roche
Phase 3 Completed